Medexus Pharmaceuticals Inc. operates as a pharmaceutical company in Canada and the United States. The company focuses on various therapeutic areas comprising allergy, dermatology, hematology, oncology, rheumatology, and rare diseases. Its…
91 employees medexus.com
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
News 2026-04-15
Medexus Provides Business Update on GRAFAPEX (treosulfan) for Injection, Capital Allocation, and Investor Conference Participation
News release - English.pdf
Ownership 2026-03-02
Nelson, Stephen William bought +$76k
Insider trading – 2026-03-02
1 insider · +$76k net
Ownership 2026-02-27
Nelson, Stephen William bought +$11k
Insider trading – 2026-02-27
1 insider · +$11k net
Results 2026-02-11
Medexus Announces Fiscal Q3 2026 Results, Driven by Continued Strong Year-To-Date Product-Level Performance of GRAFAPEX (treosulfan) for Injection
News release - English.pdf
Results 2026-02-11 Financials
Interim MD&A - English.pdf
Results 2026-02-11 Financials
Interim financial statements/report – English.pdf
Ownership 2025-12-30
Nelson, Stephen William bought +$94k
Insider trading – 2025-12-30
1 insider · +$94k net
Results 2025-11-20 Returns
Medexus Announces Normal Course Issuer Bid, or NCIB, for its Common Shares
News release (section 4.8 of NI 62-104).pdf
Transactions 2025-11-17 Financing
Medexus Announces US$51.0 million in New Credit Facilities and Intention to Commence Normal Course Issuer Bid, or NCIB, for its Common Shares
News release - English.pdf
News 2025-11-12
News release - English.pdf
News 2025-11-12
News release - English.pdf
Results 2025-11-12 Financials
Interim MD&A - English.pdf
Results 2025-11-12 Financials
Interim financial statements/report – English.pdf
News 2025-11-05
News release - English.pdf
News 2025-09-25
News release - English.pdf
Ownership 2025-08-21
Nelson, Stephen William bought +$88k
Insider trading – 2025-08-21
1 insider · +$88k net
News 2025-08-15
Other.pdf
News 2025-08-15
Other.pdf
News 2025-08-15
Other.pdf
News 2025-08-12
News release - English.pdf
Results 2025-08-12 Financials
Interim MD&A - English.pdf
Results 2025-08-12 Financials
Interim financial statements/report – English.pdf
News 2025-08-05
News release - English.pdf
News 2025-08-05
News release - English.pdf
Results 2025-06-25 Financials
Annual information form - English.pdf
Results 2025-06-25 Financials
Annual MD&A - English.pdf
News 2025-06-25
News release - English.pdf
Results 2025-06-25 Financials
Audited annual financial statements – English.pdf
News 2025-06-17
News release - English.pdf
Ownership 2024-12-10
Mueller, Mike bought +$5k
Insider trading – 2024-12-10
1 insider · +$5k net
Ownership 2024-09-24
d'Entremont, Kenneth bought +$8k
Insider trading – 2024-09-24
1 insider · +$8k net
Ownership 2024-06-28
d'Entremont, Kenneth bought +$11k
Insider trading – 2024-06-28
1 insider · +$11k net